A Randomized Controlled Trial of Tofacitinib in Combination with Deucravacitinib versus Deucravacitinib Monotherapy for Moderate-to-Severe Plaque Psoriasis (ChiCTR) - Oct 16, 2026 - P=N/A | N=120 | Recruiting | Sponsor: Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venerology, Shandong First Medical University & Shan
New trial • Dermatology • Immunology • Psoriasis
|